{"id":3351,"date":"2026-10-25T18:48:28","date_gmt":"2026-10-25T18:48:28","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?page_id=3351"},"modified":"2026-10-25T18:48:28","modified_gmt":"2026-10-25T18:48:28","slug":"compounds","status":"publish","type":"page","link":"https:\/\/lotilabs.com\/resources\/compounds\/","title":{"rendered":"Research Compound Library"},"content":{"rendered":"<style>\n@font-face{font-family:Campton;src:url(https:\/\/lotilabs.com\/wp-content\/uploads\/2026\/01\/Campton-Book.woff2) format(\"woff2\");font-weight:400;font-display:swap}@font-face{font-family:Campton;src:url(https:\/\/lotilabs.com\/wp-content\/uploads\/2026\/01\/Campton-SemiBold.woff2) format(\"woff2\");font-weight:600;font-display:swap}@font-face{font-family:Campton;src:url(https:\/\/lotilabs.com\/wp-content\/uploads\/2026\/01\/Campton-Bold.woff2) format(\"woff2\");font-weight:700;font-display:swap}\n.coa-app,.coa-app *{box-sizing:border-box}.coa-app{--navy:#090057;--deep:#040047;--dark:#040232;--sky:#58d0ff;--action:#0068c7;--surface:#f7f9fc;--ink:#333;--muted:#69727d;--border:#dfe4ed;width:100vw;margin-left:calc(50% - 50vw);font-family:Campton,\"Helvetica Neue\",Arial,sans-serif;color:var(--ink);background:var(--surface)}.coa-shell{width:min(1400px,calc(100% - 40px));margin:auto}.coa-hero{padding:82px 0 76px;color:#fff;background:radial-gradient(circle at 78% 30%,rgba(88,208,255,.13),transparent 25%),linear-gradient(160deg,var(--deep),var(--dark));overflow:hidden}.coa-hero-grid{display:grid;grid-template-columns:1.12fr .88fr;gap:50px;align-items:center}.coa-kicker,.coa-label{display:block;color:var(--sky);font-size:13px;font-weight:600;letter-spacing:.12em;text-transform:uppercase}.coa-label{color:var(--action)}.coa-hero h1{margin:15px 0 24px;color:#fff;font-size:clamp(44px,5vw,72px);font-weight:500;letter-spacing:-.035em;line-height:1.04}.coa-hero p{max-width:680px;margin:0;color:rgba(255,255,255,.8);font-size:18px;line-height:1.7}.coa-visual{position:relative;min-height:390px}.coa-visual img{position:absolute;width:49%;height:320px;object-fit:cover;object-position:center;border-radius:2px;box-shadow:0 20px 50px rgba(0,0,0,.25)}.coa-visual .p{left:27%;top:12px;z-index:3}.coa-visual .l{left:2%;top:65px;transform:rotate(-5deg)}.coa-visual .c{right:0;top:70px;transform:rotate(5deg)}.coa-count{position:absolute;right:0;top:0;z-index:4;display:grid;width:126px;height:126px;place-items:center;border:1px solid rgba(88,208,255,.5);border-radius:50%;background:rgba(9,0,87,.92);text-align:center}.coa-count strong{display:block;font-size:32px;line-height:1}.coa-count small{color:rgba(255,255,255,.72)}.coa-stats{display:grid;grid-template-columns:repeat(4,1fr);background:#fff;border-bottom:1px solid var(--border)}.coa-stat{padding:27px 30px;border-right:1px solid var(--border)}.coa-stat strong{display:block;color:var(--navy);font-size:28px}.coa-stat span{color:var(--muted);font-size:13px}.coa-library{padding:78px 0 90px}.coa-library h2.coa-heading{margin:10px 0 13px;color:var(--navy);font-size:clamp(34px,4vw,54px);line-height:1.08}.coa-intro{max-width:760px;margin:0 0 30px;color:var(--muted);font-size:17px}.coa-controls{display:grid;grid-template-columns:minmax(260px,1fr) auto;gap:18px;align-items:center;margin:30px 0}.coa-search{width:100%;height:56px;border:1px solid #aebad0;border-radius:6px;padding:0 18px;color:var(--ink);background:#fff;font:inherit}.coa-search:focus{outline:3px solid var(--sky);outline-offset:2px}.coa-filters{display:flex;flex-wrap:wrap;gap:8px}.coa-filter{min-height:44px;border:1px solid var(--border);border-radius:6px;padding:10px 16px;background:#fff;color:var(--navy);font:600 13px Campton;cursor:pointer}.coa-filter.active{border-color:var(--action);background:var(--navy);color:#fff}.coa-results{margin:0 0 18px;color:var(--muted);font-size:14px}.coa-grid{display:grid;grid-template-columns:repeat(4,minmax(0,1fr));gap:20px}.coa-card{display:flex;min-width:0;flex-direction:column;border:1px solid var(--border);border-radius:8px;background:#fff;box-shadow:0 10px 30px rgba(9,0,87,.06);overflow:hidden}.coa-card[hidden]{display:none}.coa-image{position:relative;display:block;height:285px;background:#eef1f6;overflow:hidden}.coa-image img{width:100%;height:100%;object-fit:cover;object-position:top}.coa-image span{position:absolute;right:8px;bottom:8px;left:8px;border-radius:4px;padding:7px 8px;background:rgba(9,0,87,.9);color:#fff;font-size:10px;text-align:center}.coa-card-body{padding:20px}.coa-badge{display:inline-flex;border-radius:99px;padding:5px 8px;font-size:10px;font-weight:600}.status-verified{background:#dcf6f1;color:#006f65}.status-verified_with_note,.status-archive_only{background:#e7f5fc;color:#075c85}.status-review_required{background:#fff2d0;color:#875500}.coa-card h2{margin:13px 0 14px;color:var(--navy);font-size:21px;line-height:1.22}.coa-summary{margin:0}.coa-summary>div,.coa-meta-row{display:grid;grid-template-columns:90px minmax(0,1fr);gap:10px;padding:7px 0;border-top:1px solid #edf0f5}.coa-summary dt,.coa-meta-row dt{color:var(--muted);font-size:10px;text-transform:uppercase}.coa-summary dd,.coa-meta-row dd{margin:0;color:var(--ink);font-size:11px;font-weight:500;text-align:right;overflow-wrap:anywhere}.coa-details{margin-top:15px;border-top:1px solid var(--border)}.coa-details summary{display:flex;justify-content:space-between;padding:15px 0 0;color:var(--action);font-size:12px;font-weight:600;cursor:pointer;list-style:none}.coa-details summary::-webkit-details-marker{display:none}.coa-detail-body{padding-top:15px}.coa-note{margin:14px 0;border-left:3px solid #875500;padding:11px 12px;background:#fffaf0;font-size:12px}.coa-note p{margin:4px 0 0}.coa-actions{display:grid;gap:8px;margin-top:15px}.coa-btn{display:flex;min-height:42px;align-items:center;justify-content:center;border-radius:6px;padding:10px 13px;font-size:12px;font-weight:600;text-align:center;text-decoration:none}.coa-btn-primary{background:var(--action);color:#fff!important}.coa-btn-outline{border:1px solid var(--action);color:var(--action)!important}.coa-source-note{margin:12px 0 0;color:var(--muted);font-size:10px;line-height:1.5}.coa-empty{display:none;padding:60px 20px;text-align:center;color:var(--navy)}.coa-standard{padding:58px 0;background:var(--navy);color:#fff}.coa-standard h2{margin:0 0 12px;color:#fff}.coa-standard p{max-width:900px;margin:0;color:rgba(255,255,255,.76)}.coa-howto{padding:70px 0;background:#fff;border-top:1px solid var(--border)}.coa-howto-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:22px;margin-top:26px}.coa-howto-grid>div{border:1px solid var(--border);border-radius:8px;padding:24px;background:var(--surface)}.coa-howto h2.coa-heading{margin:10px 0 0;color:var(--navy);font-family:Campton,\"Helvetica Neue\",Arial,sans-serif;font-weight:600;font-size:clamp(30px,3.4vw,46px);line-height:1.1}.coa-howto h3{margin:0 0 10px;color:var(--navy);font-family:Campton,\"Helvetica Neue\",Arial,sans-serif;font-weight:600;font-size:19px}.coa-howto p{margin:0;color:var(--ink);font-size:15px;line-height:1.65}.coa-howto a{color:var(--action)}@media(max-width:760px){.coa-howto-grid{grid-template-columns:1fr}}@media(max-width:1050px){.coa-grid{grid-template-columns:repeat(3,1fr)}.coa-hero-grid{grid-template-columns:1fr}.coa-visual{display:none}}@media(max-width:760px){.coa-shell{width:min(100% - 28px,1400px)}.coa-hero{padding:58px 0}.coa-hero h1{font-size:46px}.coa-stats{grid-template-columns:repeat(2,1fr)}.coa-stat{padding:20px}.coa-controls{grid-template-columns:1fr}.coa-grid{grid-template-columns:repeat(2,1fr)}}@media(max-width:520px){.coa-grid{grid-template-columns:1fr}.coa-stats{grid-template-columns:1fr}.coa-stat{border-bottom:1px solid var(--border)}.coa-hero h1{font-size:39px}.coa-library{padding-top:55px}.coa-image{height:390px}}\n<\/style>\n<style>\nbody.page-id-2603 #header,body.page-id-2603 #footer,body.page-id-2603 .page-title,body.page-id-2603 .absolute-footer,body.page-id-2603 .page-header-excerpt{display:none!important}\nbody.page-id-2603 #wrapper,body.page-id-2603 #main,body.page-id-2603 .page-wrapper,body.page-id-2603 .page-inner,body.page-id-2603 .row,body.page-id-2603 .col,body.page-id-2603 .col-inner{width:100%!important;max-width:none!important;margin:0!important;padding:0!important}\n.coa-app{--white:#fff;--action-live:#0386fe;overflow:hidden}\n.coa-site-header{position:relative;z-index:50;background:var(--navy);color:#fff}.coa-vip{display:grid;min-height:42px;place-items:center;padding:9px 20px;background:linear-gradient(90deg,#1804ff,#01799e);font-size:15px;line-height:1.2;text-align:center}.coa-nav-shell{background:var(--navy)}.coa-nav{display:grid;grid-template-columns:166px 1fr 92px;align-items:center;width:min(1400px,calc(100% - 40px));min-height:108px;margin:auto}.coa-logo,.coa-logo img{display:block;width:142px;height:68px;object-fit:contain}.coa-nav nav{display:flex;align-items:center;justify-content:center;gap:25px}.coa-nav nav a{position:relative;color:#fff!important;font-size:18px;font-weight:300;text-decoration:none}.coa-nav nav a:after{position:absolute;right:0;bottom:-11px;left:0;height:2px;background:var(--sky);content:\"\";opacity:0}.coa-nav nav a.active{color:var(--sky)!important;font-weight:500}.coa-nav nav a.active:after,.coa-nav nav a:hover:after{opacity:1}.coa-nav-actions{display:flex;justify-content:flex-end;gap:20px}.coa-nav-actions a{display:grid;width:28px;height:36px;place-items:center;color:#fff}.coa-nav-actions svg{width:23px;fill:none;stroke:currentColor;stroke-width:1.8}\n.coa-category-nav{display:none;background:var(--navy);color:#fff}\n.coa-hero{position:relative;min-height:590px;padding:0;background:linear-gradient(175deg,var(--deep),var(--dark))}.coa-hero:before{position:absolute;inset:0;background:radial-gradient(circle at 82% 42%,rgba(88,208,255,.22),transparent 28%),linear-gradient(130deg,transparent 44%,rgba(88,208,255,.08) 44.2%,transparent 44.6%),linear-gradient(55deg,transparent 63%,rgba(88,208,255,.08) 63.2%,transparent 63.6%);content:\"\"}.coa-hero-grid{position:relative;z-index:1;grid-template-columns:minmax(0,.95fr) minmax(460px,.75fr);min-height:590px;padding:72px 0}.coa-breadcrumbs{display:flex;align-items:center;gap:8px;margin-bottom:32px;color:rgba(255,255,255,.7);font-size:13px}.coa-breadcrumbs a{color:inherit!important;text-decoration:none}.coa-hero h1{max-width:820px;margin:0;font-size:clamp(48px,5.2vw,76px);line-height:1.04}.coa-hero p{margin:25px 0 31px;font-size:19px;font-weight:300;line-height:1.65}.coa-hero-cta{display:inline-flex;min-height:52px;align-items:center;border-radius:6px;padding:14px 30px;background:var(--action);color:#fff!important;font-size:16px;font-weight:600;text-decoration:none}.coa-visual{min-height:430px}.coa-visual img{bottom:-42px;width:auto;height:auto;object-fit:contain;border-radius:0;box-shadow:none;filter:drop-shadow(0 32px 40px rgba(0,0,0,.38))}.coa-visual .p{top:auto;bottom:-42px;left:29%;width:48%;height:430px}.coa-visual .l{top:auto;bottom:-28px;left:0;width:42%;height:350px;transform:rotate(-4deg)}.coa-visual .c{top:auto;right:-2%;bottom:-26px;width:41%;height:345px;transform:rotate(5deg)}.coa-count{top:16px;right:8px;width:132px;height:132px;border-color:rgba(255,255,255,.35);backdrop-filter:blur(8px)}\n.coa-stats{position:relative;z-index:2;width:min(1400px,calc(100% - 40px));margin:auto}.coa-stat{padding:31px 28px;border-left:1px solid var(--border);border-right:0}.coa-stat:last-child{border-right:1px solid var(--border)}\n.coa-library{padding:92px 0 110px}.coa-library h2.coa-heading{font-size:clamp(40px,4vw,58px);font-weight:500;letter-spacing:-.03em}.coa-intro{margin-top:17px;font-weight:300;line-height:1.65}.coa-controls{display:block;margin-top:42px;border-radius:8px;padding:22px;background:#fff;box-shadow:0 14px 45px rgba(9,0,87,.09)}.coa-controls label{display:flex;min-height:64px;align-items:center;border:1px solid #ccd4e0;border-radius:6px;padding:0 18px}.coa-search{height:auto;border:0;padding:0;background:transparent;outline:0!important}.coa-filters{margin-top:16px}.coa-filter{min-width:120px;border:0;border-radius:30px;padding:9px 17px;background:#0a53b7;color:#fff;font-weight:400}.coa-filter.active,.coa-filter:hover{background:var(--navy);color:#fff}.coa-results{margin:25px 0 0;border-left:4px solid var(--sky);border-radius:0 6px 6px 0;padding:17px 20px;background:#eaf8ff;color:var(--navy)}\n.coa-grid{grid-template-columns:repeat(3,minmax(0,1fr));gap:24px;margin-top:34px;align-items:start}.coa-card{display:grid;grid-template-columns:150px minmax(0,1fr);min-height:290px;box-shadow:0 5px 20px rgba(9,0,87,.045)}.coa-image{height:auto;border-right:1px solid var(--border)}.coa-image img{min-height:290px}.coa-card-body{display:flex;min-width:0;flex-direction:column}.coa-details{margin-top:auto}.coa-card h2{font-weight:600}\n.coa-standard{padding:85px 0}.coa-standard h2{font-size:42px;font-weight:500}\n.coa-footer{background:#fff;color:var(--navy)}.coa-footer-main{display:grid;grid-template-columns:1.6fr repeat(3,1fr);gap:70px;padding:78px 0 58px}.coa-footer-about img{width:150px}.coa-footer p{color:var(--muted);font-size:14px;line-height:1.65}.coa-footer h3{margin:0 0 20px;color:var(--navy);font-size:16px}.coa-footer-main>div>a{display:block;margin:0 0 11px;color:var(--muted)!important;font-size:14px;text-decoration:none}.coa-tagline{margin-top:28px!important;color:var(--navy)!important;font-size:18px!important;font-weight:600}.coa-footer-bottom{display:flex;justify-content:space-between;border-top:1px solid var(--border);padding:22px 0;color:var(--muted);font-size:12px}.coa-ruo{padding:15px 20px;background:var(--navy);color:rgba(255,255,255,.78);font-size:12px;text-align:center}\n@media(max-width:1050px){.coa-nav{grid-template-columns:150px 1fr}.coa-nav nav{display:none}.coa-nav-actions{display:flex}.coa-hero-grid{grid-template-columns:1fr}.coa-visual{display:none}.coa-grid{grid-template-columns:repeat(2,minmax(0,1fr))}.coa-footer-main{grid-template-columns:1fr 1fr}}\n@media(max-width:760px){.coa-vip{padding:9px 6px;font-size:clamp(9px,2.82vw,12px);white-space:nowrap}.coa-nav{min-height:82px}.coa-site-header .coa-logo,.coa-site-header .coa-logo img{width:122px;height:58px}.coa-category-nav{display:grid;grid-template-columns:repeat(3,minmax(0,1fr));width:100%;gap:0;overflow:hidden;padding:0;border-top:1px solid rgba(255,255,255,.12);border-bottom:1px solid rgba(255,255,255,.12)}.coa-category-nav a{display:grid;min-width:0;min-height:46px;place-items:center;border:0;border-right:1px solid rgba(88,208,255,.45);border-radius:0;padding:9px 12px;background:rgba(88,208,255,.12);color:#fff!important;font-size:12px;font-weight:600;text-align:center;text-decoration:none}.coa-category-nav a:last-child{border-right:0}.coa-category-nav a:first-child{border-color:var(--sky);background:var(--sky);color:var(--navy)!important}.coa-hero,.coa-hero-grid{min-height:0}.coa-hero-grid{padding:58px 0}.coa-breadcrumbs{margin-bottom:24px}.coa-stats{width:100%;grid-template-columns:repeat(2,1fr)}.coa-grid{grid-template-columns:1fr}.coa-card{display:block;min-height:0}.coa-image{height:235px;border-right:0;border-bottom:1px solid var(--border);padding:12px;background:linear-gradient(145deg,#f8faff,#edf2f8)}.coa-image img{width:100%;height:100%;min-height:0;object-fit:contain;object-position:center;filter:drop-shadow(0 5px 10px rgba(9,0,87,.12))}.coa-image span{right:12px;bottom:12px;left:auto;padding:8px 12px;font-size:11px}.coa-footer-main{grid-template-columns:1fr;gap:30px}.coa-footer-bottom{flex-direction:column;gap:8px}}\n@media(max-width:520px){.coa-hero h1{font-size:44px}.coa-library{padding:62px 0 80px}.coa-image{height:220px}.coa-filter{min-width:0}}\n<\/style>\n<style>\n.cmp-main{padding:40px 0 90px;background:#f7f9fc}\n.cmp-crumbs{display:flex;flex-wrap:wrap;gap:8px;margin-bottom:22px;color:#69727d;font-size:13px}\n.cmp-crumbs a{color:#0068c7!important;text-decoration:none}\n.cmp-head h1{margin:12px 0 12px;color:#090057;font-size:clamp(34px,4.6vw,56px);font-weight:500;letter-spacing:-.02em;line-height:1.06}\n.cmp-lead{max-width:780px;margin:0 0 28px;color:#69727d;font-size:17px;line-height:1.6}\n.cmp-grid{display:grid;grid-template-columns:minmax(260px,360px) minmax(0,1fr);gap:24px;align-items:start}\n.cmp-card{border:1px solid #dfe4ed;border-radius:10px;background:#fff;box-shadow:0 12px 36px rgba(9,0,87,.06);padding:24px}\n.cmp-img img{display:block;width:100%!important;height:auto!important;border-radius:8px}\n.cmp-img small{display:block;margin-top:10px;color:#69727d;font-size:12px;line-height:1.45}\n.cmp-card h2,.cmp-sec h2{margin:0 0 14px;color:#090057;font-size:26px;font-weight:500}\n.cmp-card h3{margin:18px 0 8px;color:#090057;font-size:15px;font-weight:600}\n.cmp-spec{width:100%;border-collapse:collapse;font-size:14px}\n.cmp-spec td{padding:11px 0;border-bottom:1px solid #dfe4ed;vertical-align:top;color:#333}\n.cmp-spec td:first-child{width:40%;padding-right:12px;color:#69727d;font-size:11px;letter-spacing:.08em;text-transform:uppercase;padding-top:13px}\n.cmp-spec td:last-child{font-weight:600;overflow-wrap:anywhere;color:#090057}\n.cmp-spec a{color:#0068c7!important}\n.cmp-sec{margin-top:24px}\n.cmp-cur{display:grid;grid-template-columns:repeat(auto-fill,minmax(290px,1fr));gap:16px}\n.cmp-cur .cmp-card{padding:20px}\n.cmp-pill{display:inline-flex;border-radius:99px;padding:5px 10px;background:#dcf6f1;color:#006f65;font-size:11px;font-weight:600;margin-bottom:10px}\n.cmp-fmt{margin:0 0 12px;color:#090057;font-size:18px;font-weight:600}\n.cmp-stats{display:grid;grid-template-columns:1fr 1fr;gap:8px;margin-bottom:12px}\n.cmp-stats div{border-radius:8px;background:#f2f5fb;padding:10px 12px}\n.cmp-stats b{display:block;color:#090057;font-size:19px;font-weight:600}\n.cmp-stats span{color:#69727d;font-size:12px}\n.cmp-meta{margin:0 0 14px;color:#69727d;font-size:13px;line-height:1.6}\n.cmp-meta strong{color:#333;font-weight:600}\n.cmp-btns{display:flex;flex-wrap:wrap;gap:8px}\n.cmp-btns .coa-btn{min-width:150px}\n.cmp-tw{overflow-x:auto;-webkit-overflow-scrolling:touch;border:1px solid #dfe4ed;border-radius:10px;background:#fff}\n.cmp-hist{width:100%;border-collapse:collapse;font-size:14px;min-width:620px}\n.cmp-hist th{padding:12px 14px;border-bottom:1px solid #dfe4ed;color:#69727d;font-size:11px;font-weight:600;letter-spacing:.08em;text-align:left;text-transform:uppercase}\n.cmp-hist td{padding:12px 14px;border-bottom:1px solid #eef1f6;color:#333;white-space:nowrap}\n.cmp-hist tr:last-child td{border-bottom:0}\n.cmp-hist a{color:#0068c7!important;font-weight:600}\n.cmp-p{max-width:820px;color:#333;font-size:15px;line-height:1.7}\n.cmp-p a{color:#0068c7!important}\n.cmp-faq details{border-bottom:1px solid #dfe4ed;padding:15px 0}\n.cmp-faq summary{color:#090057;font-size:16px;font-weight:600;cursor:pointer}\n.cmp-faq p{max-width:820px;margin:8px 0 0;color:#333;font-size:15px;line-height:1.6}\n.cmp-cta{display:flex;align-items:center;justify-content:space-between;gap:20px;margin-top:28px;border-radius:10px;background:#090057;padding:26px}\n.cmp-cta h2{margin:0;color:#fff;font-size:21px;font-weight:500}\n.cmp-cta p{margin:4px 0 0;color:#c9c6f0;font-size:14px}\n.cmp-cta a{flex:none;border-radius:6px;padding:12px 18px;background:#58d0ff;color:#090057!important;font-size:14px;font-weight:600;text-decoration:none}\n.cmp-ruo{margin-top:22px;color:#69727d;font-size:12px;line-height:1.55}\n.cmp-lib-controls{margin:0 0 22px}\n.cmp-lib-controls input{width:100%;max-width:520px;min-height:46px;border:1px solid #dfe4ed!important;border-radius:6px!important;padding:10px 14px!important;font-size:15px;background:#fff}\n.cmp-lib h2{margin:30px 0 14px;color:#090057;font-size:24px;font-weight:500}\n.cmp-lib-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(250px,1fr));gap:14px}\n.cmp-tile{display:block;border:1px solid #dfe4ed;border-radius:10px;background:#fff;padding:18px;text-decoration:none!important;transition:border-color .15s}\n.cmp-tile:hover{border-color:#0068c7}\n.cmp-tile strong{display:block;color:#090057;font-size:17px;font-weight:600}\n.cmp-tile span{display:block;margin-top:4px;color:#69727d;font-size:13px;line-height:1.45}\n.cmp-tile em{display:block;margin-top:10px;color:#006f65;font-size:12px;font-style:normal;font-weight:600}\n@media(max-width:800px){.cmp-grid{grid-template-columns:1fr}.cmp-img{max-width:320px}.cmp-card{padding:18px}.cmp-cta{flex-direction:column;align-items:flex-start}.cmp-main{padding:28px 0 70px}}\n<\/style>\n<style>body.page-id-3351 #header,body.page-id-3351 #footer,body.page-id-3351 .page-title,body.page-id-3351 .absolute-footer,body.page-id-3351 .page-header-excerpt{display:none!important}body.page-id-3351 #wrapper,body.page-id-3351 #main,body.page-id-3351 .page-wrapper,body.page-id-3351 .page-inner,body.page-id-3351 .row,body.page-id-3351 .col,body.page-id-3351 .col-inner{width:100%!important;max-width:none!important;margin:0!important;padding:0!important}<\/style>\n<div class=\"coa-app\">\n<header class=\"coa-site-header\">\n<div class=\"coa-vip\"><span>Text <strong>\u201cLoti\u201d<\/strong> to <strong>833-962-6682<\/strong> to join the Loti Labs VIP Group!<\/span><\/div>\n<div class=\"coa-nav-shell\">\n<div class=\"coa-nav\"><a class=\"coa-logo\" href=\"https:\/\/lotilabs.com\/\" aria-label=\"Loti Labs home\"><img decoding=\"async\" src=\"https:\/\/lotilabs.com\/wp-content\/uploads\/2026\/09\/lotilabs-logo.png\" alt=\"Loti Labs\"><\/a><\/p>\n<nav aria-label=\"Loti Labs main navigation\"><a href=\"https:\/\/lotilabs.com\/\" class=\"\">Home<\/a><a href=\"https:\/\/lotilabs.com\/research-liquids\/\" class=\"\">Liquids<\/a><a href=\"https:\/\/lotilabs.com\/peptides\/\" class=\"\">Peptides<\/a><a href=\"https:\/\/lotilabs.com\/capsules\/\" class=\"\">Capsules<\/a><a href=\"https:\/\/lotilabs.com\/catalog\/\" class=\"\">All<\/a><a href=\"https:\/\/lotilabs.com\/faq\/\" class=\"\">FAQs<\/a><a href=\"https:\/\/lotilabs.com\/resources\/coa-archive\/\" class=\"active\">COAs<\/a><a href=\"https:\/\/lotilabs.com\/contact-us\/\" class=\"\">Contact<\/a><a href=\"https:\/\/lotilabs.com\/track-order\/\" class=\"\">Track<\/a><\/nav>\n<div class=\"coa-nav-actions\"><a href=\"https:\/\/lotilabs.com\/my-account\/\" aria-label=\"My account\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"8\" r=\"4\"\/><path d=\"M4 21a8 8 0 0 1 16 0\"\/><\/svg><\/a><a href=\"https:\/\/lotilabs.com\/cart\/\" aria-label=\"Shopping cart\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M6 7h12l-1 14H7L6 7Z\"\/><path d=\"M9 7a3 3 0 0 1 6 0\"\/><\/svg><\/a><\/div>\n<\/div>\n<\/div>\n<div class=\"coa-category-nav\"><a href=\"https:\/\/lotilabs.com\/peptides\/\">Peptides<\/a><a href=\"https:\/\/lotilabs.com\/capsules\/\">Capsules<\/a><a href=\"https:\/\/lotilabs.com\/research-liquids\/\">Liquids<\/a><\/div>\n<\/header>\n<p><main class=\"cmp-main\"><\/p>\n<div class=\"coa-shell\">\n<nav class=\"cmp-crumbs\" aria-label=\"Breadcrumb\"><a href=\"https:\/\/lotilabs.com\/\">Home<\/a><span>\u203a<\/span><span>Compound library<\/span><\/nav>\n<header class=\"cmp-head\"><span class=\"coa-label\">Loti Labs resources<\/span><\/p>\n<h1>Research compound library<\/h1>\n<p class=\"cmp-lead\">Specifications, current certificates of analysis and batch history for every compound in the Loti Labs catalog. Each batch is tested by an independent, U.S.-based third-party laboratory.<\/p>\n<\/header>\n<div class=\"cmp-lib-controls\"><label><span style=\"position:absolute;left:-9999px\">Search compounds<\/span><input type=\"search\" placeholder=\"Search compounds\"><\/label><\/div>\n<section class=\"cmp-lib\" data-group>\n<h2>Peptides<\/h2>\n<div class=\"cmp-lib-grid\"><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/5-amino-1mq\/\" data-q=\"5-amino-1mq methylquinolinium iodide \"><strong>5-Amino-1MQ<\/strong><span>Methylquinolinium iodide<\/span><span>10 mg vial, 50 mg per capsule, 30 capsules<\/span><em>Latest COA 99.8% \u00b7 Jun 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/aod-9604\/\" data-q=\"aod-9604 synthetic 16-residue peptide \"><strong>AOD-9604<\/strong><span>Synthetic 16-residue peptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.48% \u00b7 Feb 6, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/bpc-157\/\" data-q=\"bpc-157 synthetic pentadecapeptide \"><strong>BPC-157<\/strong><span>Synthetic pentadecapeptide<\/span><span>5 mg vial, 500 mcg per capsule, 30 capsules<\/span><em>Latest COA 99.5% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/cagrilintide\/\" data-q=\"cagrilintide synthetic acylated peptide \"><strong>Cagrilintide<\/strong><span>Synthetic acylated peptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.9% \u00b7 Jun 29, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/cjc-1295-dac\/\" data-q=\"cjc-1295 with dac with dac \"><strong>CJC-1295 with DAC<\/strong><span>With DAC<\/span><span>2 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/cjc-1295-no-dac\/\" data-q=\"cjc-1295 without dac without dac (mod grf 1-29) modified grf (1-29)\"><strong>CJC-1295 without DAC<\/strong><span>Without DAC (Mod GRF 1-29)<\/span><span>2 mg vial<\/span><em>Latest COA 99.9% \u00b7 May 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/dihexa\/\" data-q=\"dihexa synthetic peptide derivative \"><strong>Dihexa<\/strong><span>Synthetic peptide derivative<\/span><span>10 mg vial<\/span><em>Latest COA 99.7% \u00b7 Jul 9, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/dsip\/\" data-q=\"dsip synthetic nonapeptide delta sleep-inducing peptide (dsip)\"><strong>DSIP<\/strong><span>Synthetic nonapeptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.71% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/epitalon\/\" data-q=\"epitalon synthetic tetrapeptide \"><strong>Epitalon<\/strong><span>Synthetic tetrapeptide<\/span><span>10 mg vial, 3 mg per capsule, 30 capsules<\/span><em>Latest COA 99.9% \u00b7 May 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/fragment-176-191\/\" data-q=\"fragment 176-191 synthetic 16-residue peptide \"><strong>Fragment 176-191<\/strong><span>Synthetic 16-residue peptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.82% \u00b7 Feb 4, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/ghk-cu\/\" data-q=\"ghk-cu copper tripeptide complex \"><strong>GHK-Cu<\/strong><span>Copper tripeptide complex<\/span><span>50 mg vial, 2 mg per capsule, 30 capsules<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/ghrp-2\/\" data-q=\"ghrp-2 synthetic hexapeptide pralmorelin (ghrp-2)\"><strong>GHRP-2<\/strong><span>Synthetic hexapeptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.69% \u00b7 Feb 4, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/ghrp-6\/\" data-q=\"ghrp-6 synthetic hexapeptide \"><strong>GHRP-6<\/strong><span>Synthetic hexapeptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.41% \u00b7 Feb 4, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/glutathione\/\" data-q=\"glutathione reduced tripeptide \"><strong>Glutathione<\/strong><span>Reduced tripeptide<\/span><span>600 mg vial, 1500 mg vial<\/span><em>Latest COA 99.89% \u00b7 Feb 5, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/gnrh-triptorelin\/\" data-q=\"gnrh (triptorelin) synthetic decapeptide \"><strong>GnRH (Triptorelin)<\/strong><span>Synthetic decapeptide<\/span><span>100 mcg vial<\/span><em>Latest COA 99.39% \u00b7 Feb 6, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/hexarelin\/\" data-q=\"hexarelin synthetic hexapeptide \"><strong>Hexarelin<\/strong><span>Synthetic hexapeptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.8% \u00b7 May 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/igf-1-lr3\/\" data-q=\"igf-1 lr3 synthetic 83-residue analog \"><strong>IGF-1 LR3<\/strong><span>Synthetic 83-residue analog<\/span><span>1 mg vial<\/span><em>Latest COA 99.8% \u00b7 Jun 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/ipamorelin\/\" data-q=\"ipamorelin synthetic pentapeptide \"><strong>Ipamorelin<\/strong><span>Synthetic pentapeptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.98% \u00b7 Feb 1, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/kisspeptin-10\/\" data-q=\"kisspeptin-10 synthetic decapeptide \"><strong>Kisspeptin-10<\/strong><span>Synthetic decapeptide<\/span><span>5 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/kpv\/\" data-q=\"kpv synthetic tripeptide \"><strong>KPV<\/strong><span>Synthetic tripeptide<\/span><span>5 mg vial, 500 mcg per capsule, 30 capsules<\/span><em>Latest COA 99.82% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/ll-37\/\" data-q=\"ll-37 synthetic 37-residue peptide \"><strong>LL-37<\/strong><span>Synthetic 37-residue peptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.57% \u00b7 Feb 4, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/mazdutide\/\" data-q=\"mazdutide synthetic acylated peptide \"><strong>Mazdutide<\/strong><span>Synthetic acylated peptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.70% \u00b7 Feb 3, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/melanotan-2\/\" data-q=\"melanotan 2 synthetic cyclic heptapeptide \"><strong>Melanotan 2<\/strong><span>Synthetic cyclic heptapeptide<\/span><span>10 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/mgf\/\" data-q=\"mgf synthetic e-domain peptide mechano growth factor (mgf)\"><strong>MGF<\/strong><span>Synthetic E-domain peptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.22% \u00b7 Feb 6, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/mots-c\/\" data-q=\"mots-c synthetic 16-residue peptide \"><strong>MOTS-c<\/strong><span>Synthetic 16-residue peptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.81% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/nad\/\" data-q=\"nad+ dinucleotide coenzyme \"><strong>NAD+<\/strong><span>Dinucleotide coenzyme<\/span><span>500 mg vial<\/span><em>Latest COA 99.82% \u00b7 Aug 10, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/oxytocin\/\" data-q=\"oxytocin synthetic cyclic nonapeptide \"><strong>Oxytocin<\/strong><span>Synthetic cyclic nonapeptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.68% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/pinealon\/\" data-q=\"pinealon synthetic tripeptide glu-asp-arg (pinealon)\"><strong>Pinealon<\/strong><span>Synthetic tripeptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.87% \u00b7 Feb 3, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/pt-141\/\" data-q=\"pt-141 synthetic cyclic heptapeptide bremelanotide (pt-141)\"><strong>PT-141<\/strong><span>Synthetic cyclic heptapeptide<\/span><span>10 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/selank\/\" data-q=\"selank synthetic heptapeptide \"><strong>Selank<\/strong><span>Synthetic heptapeptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.9% \u00b7 Jun 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/semaglutide\/\" data-q=\"sema (semaglutide) synthetic acylated peptide semaglutide\"><strong>Sema (Semaglutide)<\/strong><span>Synthetic acylated peptide<\/span><span>5 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/semax\/\" data-q=\"semax synthetic heptapeptide \"><strong>Semax<\/strong><span>Synthetic heptapeptide<\/span><span>5 mg vial<\/span><em>Latest COA 99.9% \u00b7 Jun 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/sermorelin\/\" data-q=\"sermorelin synthetic 29-residue peptide \"><strong>Sermorelin<\/strong><span>Synthetic 29-residue peptide<\/span><span>2 mg vial<\/span><em>Latest COA 99.61% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/snap-8\/\" data-q=\"snap-8 synthetic octapeptide \"><strong>SNAP-8<\/strong><span>Synthetic octapeptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.86% \u00b7 Feb 4, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/survodutide\/\" data-q=\"survodutide synthetic acylated peptide \"><strong>Survodutide<\/strong><span>Synthetic acylated peptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.81% \u00b7 Oct 27, 2025<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/tb-500\/\" data-q=\"tb-500 synthetic 43-residue peptide \"><strong>TB-500<\/strong><span>Synthetic 43-residue peptide<\/span><span>2 mg vial, 5 mg vial<\/span><em>Latest COA 99.87% \u00b7 Feb 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/tesamorelin\/\" data-q=\"tesamorelin synthetic 44-residue peptide \"><strong>Tesamorelin<\/strong><span>Synthetic 44-residue peptide<\/span><span>2 mg vial, 10 mg vial<\/span><em>Latest COA 99.9% \u00b7 May 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/thymosin-alpha-1\/\" data-q=\"thymosin alpha 1 synthetic 28-residue peptide \"><strong>Thymosin Alpha 1<\/strong><span>Synthetic 28-residue peptide<\/span><span>10 mg vial<\/span><em>Latest COA 99.74% \u00b7 Jul 27, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/tirzepatide\/\" data-q=\"tirz (tirzepatide) synthetic 39-residue peptide tirzepatide\"><strong>Tirz (Tirzepatide)<\/strong><span>Synthetic 39-residue peptide<\/span><span>5 mg vial, 10 mg vial, 30 mg vial, 50 mg vial<\/span><em>Latest COA &gt;99.9% \u00b7 Oct 12, 2026<\/em><\/a><\/div>\n<\/section>\n<section class=\"cmp-lib\" data-group>\n<h2>Research liquids<\/h2>\n<div class=\"cmp-lib-grid\"><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/anastrozole\/\" data-q=\"anastrozole non-steroidal triazole \"><strong>Anastrozole<\/strong><span>Non-steroidal triazole<\/span><span>1 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.24% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/clenbuterol\/\" data-q=\"clenbuterol phenylaminoethanol compound \"><strong>Clenbuterol<\/strong><span>Phenylaminoethanol compound<\/span><span>200 mcg\/mL liquid, 30 mL<\/span><em>Latest COA 99.48% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/clomiphene\/\" data-q=\"clomiphene clomiphene citrate \"><strong>Clomiphene<\/strong><span>Clomiphene citrate<\/span><span>40 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.9% \u00b7 Jun 29, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/dutasteride\/\" data-q=\"dutasteride synthetic 4-azasteroid \"><strong>Dutasteride<\/strong><span>Synthetic 4-azasteroid<\/span><span>0.5 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.76% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/enclomiphene\/\" data-q=\"enclomiphene enclomiphene citrate \"><strong>Enclomiphene<\/strong><span>Enclomiphene citrate<\/span><span>25 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.53% \u00b7 Sep 11, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/exemestane\/\" data-q=\"exemestane synthetic steroidal compound \"><strong>Exemestane<\/strong><span>Synthetic steroidal compound<\/span><span>25 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.71% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/gw501516\/\" data-q=\"gw501516 synthetic thiazole compound \"><strong>GW501516<\/strong><span>Synthetic thiazole compound<\/span><span>10 mg\/mL liquid, 30 mL, 10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.79% \u00b7 Aug 6, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/letrozole\/\" data-q=\"letrozole non-steroidal triazole \"><strong>Letrozole<\/strong><span>Non-steroidal triazole<\/span><span>2.5 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.33% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/lgd-4033\/\" data-q=\"lgd-4033 non-steroidal research compound \"><strong>LGD-4033<\/strong><span>Non-steroidal research compound<\/span><span>10 mg\/mL liquid, 30 mL, 10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.8% \u00b7 Jun 29, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/mk-2866\/\" data-q=\"mk-2866 non-steroidal research compound enobosarm (mk-2866)\"><strong>MK-2866<\/strong><span>Non-steroidal research compound<\/span><span>33 mg\/mL liquid, 30 mL, 12.5 mg per capsule, 30 capsules<\/span><em>Latest COA 99.48% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/mk-677\/\" data-q=\"mk-677 non-peptide research compound ibutamoren (mk-677)\"><strong>MK-677<\/strong><span>Non-peptide research compound<\/span><span>25 mg\/mL liquid, 30 mL, 10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.91% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/pramipexole\/\" data-q=\"pramipexole aminobenzothiazole compound \"><strong>Pramipexole<\/strong><span>Aminobenzothiazole compound<\/span><span>2 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.23% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/rad-140\/\" data-q=\"rad-140 non-steroidal research compound \"><strong>RAD-140<\/strong><span>Non-steroidal research compound<\/span><span>10 mg\/mL liquid, 30 mL, 10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.8% \u00b7 Jun 29, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/sildenafil\/\" data-q=\"sildenafil sildenafil citrate \"><strong>Sildenafil<\/strong><span>Sildenafil citrate<\/span><span>50 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.12% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/slu-pp-332\/\" data-q=\"slu-pp-332 synthetic benzamide compound \"><strong>SLU-PP-332<\/strong><span>Synthetic benzamide compound<\/span><span>25 mg\/mL liquid, 30 mL, 50 mg per capsule, 30 capsules, 250 mcg per capsule, 30 capsules<\/span><em>Latest COA 99.91% \u00b7 Nov 15, 2025<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/t3\/\" data-q=\"t3 liothyronine liothyronine (t3)\"><strong>T3<\/strong><span>Liothyronine<\/span><span>100 mcg\/mL liquid, 30 mL<\/span><em>Latest COA 99.18% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/t4\/\" data-q=\"t4 levothyroxine levothyroxine (t4)\"><strong>T4<\/strong><span>Levothyroxine<\/span><span>400 mcg\/mL liquid, 30 mL<\/span><em>Latest COA 99.62% \u00b7 Mar 21, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/tadalafil\/\" data-q=\"tadalafil synthetic \u03b2-carboline compound \"><strong>Tadalafil<\/strong><span>Synthetic \u03b2-carboline compound<\/span><span>30 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.51% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/tamoxifen-citrate\/\" data-q=\"tamoxifen citrate tamoxifen citrate \"><strong>Tamoxifen citrate<\/strong><span>Tamoxifen citrate<\/span><span>20 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.19% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/yk-11\/\" data-q=\"yk-11 synthetic steroidal compound \"><strong>YK-11<\/strong><span>Synthetic steroidal compound<\/span><span>10 mg\/mL liquid, 30 mL<\/span><em>Latest COA 99.81% \u00b7 Dec 19, 2025<\/em><\/a><\/div>\n<\/section>\n<section class=\"cmp-lib\" data-group>\n<h2>Capsules<\/h2>\n<div class=\"cmp-lib-grid\"><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/bam15\/\" data-q=\"bam15 synthetic oxadiazolopyrazine \"><strong>BAM15<\/strong><span>Synthetic oxadiazolopyrazine<\/span><span>10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.23% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/gw0742\/\" data-q=\"gw0742 synthetic thiazole compound \"><strong>GW0742<\/strong><span>Synthetic thiazole compound<\/span><span>10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.19% \u00b7 Mar 2, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/methylene-blue\/\" data-q=\"methylene blue methylthioninium chloride methylthioninium chloride\"><strong>Methylene Blue<\/strong><span>Methylthioninium chloride<\/span><span>10 mg per capsule, 30 capsules<\/span><em>Latest COA 98.17% \u00b7 Apr 17, 2026<\/em><\/a><a class=\"cmp-tile\" href=\"https:\/\/lotilabs.com\/resources\/compounds\/sr9009\/\" data-q=\"sr9009 synthetic nitrothiophene compound \"><strong>SR9009<\/strong><span>Synthetic nitrothiophene compound<\/span><span>10 mg per capsule, 30 capsules<\/span><em>Latest COA 99.99% \u00b7 Aug 5, 2025<\/em><\/a><\/div>\n<\/section>\n<p class=\"cmp-ruo\">RESEARCH USE ONLY. This library is provided for laboratory, analytical and research reference. Products are not drugs, foods or cosmetics and are not for human or veterinary use. <a href=\"https:\/\/lotilabs.com\/resources\/coa-archive\/\">Search the complete COA archive<\/a>.<\/p>\n<\/div>\n<p><\/main><\/p>\n<footer class=\"coa-footer\">\n<div class=\"coa-shell coa-footer-main\">\n<div class=\"coa-footer-about\"><img decoding=\"async\" src=\"https:\/\/lotilabs.com\/wp-content\/uploads\/2026\/01\/logo-color.svg\" alt=\"Loti Labs\"><\/p>\n<p>Loti Labs is the culmination of over a decade of industry experience, bringing researchers a boutique store built around personalized service, purity, and transparency.<\/p>\n<\/div>\n<div>\n<h3>Customer Care<\/h3>\n<p><a href=\"https:\/\/lotilabs.com\/contact-us\/\">Contact<\/a><a href=\"https:\/\/lotilabs.com\/my-account\/\">My Account<\/a><a href=\"https:\/\/lotilabs.com\/track-order\/\">Track your order<\/a><a href=\"https:\/\/lotilabs.com\/faq\/\">FAQs<\/a><\/div>\n<div>\n<h3>Resources<\/h3>\n<p><a href=\"https:\/\/lotilabs.com\/resources\/\">Blog<\/a><a href=\"https:\/\/lotilabs.com\/resources\/coa-archive\/\">COA Archive<\/a><a href=\"https:\/\/lotilabs.com\/about-us\/\">About Us<\/a><a href=\"https:\/\/lotilabs.com\/privacy-policy\/\">Privacy Policy<\/a><\/div>\n<div>\n<h3>Our Email<\/h3>\n<p><a href=\"mailto:service@lotilabs.com\">service@lotilabs.com<\/a><\/p>\n<p class=\"coa-tagline\">Peptide Purity.<br \/>Science Delivered.<\/p>\n<\/div>\n<\/div>\n<div class=\"coa-shell coa-footer-bottom\"><span>\u00a9 2026 LotiLabs. All Rights Reserved.<\/span><span>For laboratory, analytical, and research use only.<\/span><\/div>\n<div class=\"coa-ruo\">All products and documentation on this site are intended strictly for research and development use only and are not for human consumption.<\/div>\n<\/footer>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"CollectionPage\",\"@id\":\"https:\/\/lotilabs.com\/resources\/compounds\/#webpage\",\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/\",\"name\":\"Research compound library | Loti Labs\",\"isPartOf\":{\"@type\":\"WebSite\",\"name\":\"Loti Labs Resources\",\"url\":\"https:\/\/lotilabs.com\/resources\/\"}},{\"@type\":\"ItemList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/5-amino-1mq\/\",\"name\":\"5-Amino-1MQ\"},{\"@type\":\"ListItem\",\"position\":2,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/anastrozole\/\",\"name\":\"Anastrozole\"},{\"@type\":\"ListItem\",\"position\":3,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/aod-9604\/\",\"name\":\"AOD-9604\"},{\"@type\":\"ListItem\",\"position\":4,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/bam15\/\",\"name\":\"BAM15\"},{\"@type\":\"ListItem\",\"position\":5,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/bpc-157\/\",\"name\":\"BPC-157\"},{\"@type\":\"ListItem\",\"position\":6,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/cagrilintide\/\",\"name\":\"Cagrilintide\"},{\"@type\":\"ListItem\",\"position\":7,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/cjc-1295-dac\/\",\"name\":\"CJC-1295 with DAC\"},{\"@type\":\"ListItem\",\"position\":8,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/cjc-1295-no-dac\/\",\"name\":\"CJC-1295 without DAC\"},{\"@type\":\"ListItem\",\"position\":9,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/clenbuterol\/\",\"name\":\"Clenbuterol\"},{\"@type\":\"ListItem\",\"position\":10,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/clomiphene\/\",\"name\":\"Clomiphene\"},{\"@type\":\"ListItem\",\"position\":11,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/dihexa\/\",\"name\":\"Dihexa\"},{\"@type\":\"ListItem\",\"position\":12,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/dsip\/\",\"name\":\"DSIP\"},{\"@type\":\"ListItem\",\"position\":13,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/dutasteride\/\",\"name\":\"Dutasteride\"},{\"@type\":\"ListItem\",\"position\":14,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/enclomiphene\/\",\"name\":\"Enclomiphene\"},{\"@type\":\"ListItem\",\"position\":15,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/epitalon\/\",\"name\":\"Epitalon\"},{\"@type\":\"ListItem\",\"position\":16,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/exemestane\/\",\"name\":\"Exemestane\"},{\"@type\":\"ListItem\",\"position\":17,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/fragment-176-191\/\",\"name\":\"Fragment 176-191\"},{\"@type\":\"ListItem\",\"position\":18,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/ghk-cu\/\",\"name\":\"GHK-Cu\"},{\"@type\":\"ListItem\",\"position\":19,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/ghrp-2\/\",\"name\":\"GHRP-2\"},{\"@type\":\"ListItem\",\"position\":20,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/ghrp-6\/\",\"name\":\"GHRP-6\"},{\"@type\":\"ListItem\",\"position\":21,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/glutathione\/\",\"name\":\"Glutathione\"},{\"@type\":\"ListItem\",\"position\":22,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/gnrh-triptorelin\/\",\"name\":\"GnRH (Triptorelin)\"},{\"@type\":\"ListItem\",\"position\":23,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/gw0742\/\",\"name\":\"GW0742\"},{\"@type\":\"ListItem\",\"position\":24,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/gw501516\/\",\"name\":\"GW501516\"},{\"@type\":\"ListItem\",\"position\":25,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/hexarelin\/\",\"name\":\"Hexarelin\"},{\"@type\":\"ListItem\",\"position\":26,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/igf-1-lr3\/\",\"name\":\"IGF-1 LR3\"},{\"@type\":\"ListItem\",\"position\":27,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/ipamorelin\/\",\"name\":\"Ipamorelin\"},{\"@type\":\"ListItem\",\"position\":28,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/kisspeptin-10\/\",\"name\":\"Kisspeptin-10\"},{\"@type\":\"ListItem\",\"position\":29,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/kpv\/\",\"name\":\"KPV\"},{\"@type\":\"ListItem\",\"position\":30,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/letrozole\/\",\"name\":\"Letrozole\"},{\"@type\":\"ListItem\",\"position\":31,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/lgd-4033\/\",\"name\":\"LGD-4033\"},{\"@type\":\"ListItem\",\"position\":32,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/ll-37\/\",\"name\":\"LL-37\"},{\"@type\":\"ListItem\",\"position\":33,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/mazdutide\/\",\"name\":\"Mazdutide\"},{\"@type\":\"ListItem\",\"position\":34,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/melanotan-2\/\",\"name\":\"Melanotan 2\"},{\"@type\":\"ListItem\",\"position\":35,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/methylene-blue\/\",\"name\":\"Methylene Blue\"},{\"@type\":\"ListItem\",\"position\":36,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/mgf\/\",\"name\":\"MGF\"},{\"@type\":\"ListItem\",\"position\":37,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/mk-2866\/\",\"name\":\"MK-2866\"},{\"@type\":\"ListItem\",\"position\":38,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/mk-677\/\",\"name\":\"MK-677\"},{\"@type\":\"ListItem\",\"position\":39,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/mots-c\/\",\"name\":\"MOTS-c\"},{\"@type\":\"ListItem\",\"position\":40,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/nad\/\",\"name\":\"NAD+\"},{\"@type\":\"ListItem\",\"position\":41,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/oxytocin\/\",\"name\":\"Oxytocin\"},{\"@type\":\"ListItem\",\"position\":42,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/pinealon\/\",\"name\":\"Pinealon\"},{\"@type\":\"ListItem\",\"position\":43,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/pramipexole\/\",\"name\":\"Pramipexole\"},{\"@type\":\"ListItem\",\"position\":44,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/pt-141\/\",\"name\":\"PT-141\"},{\"@type\":\"ListItem\",\"position\":45,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/rad-140\/\",\"name\":\"RAD-140\"},{\"@type\":\"ListItem\",\"position\":46,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/selank\/\",\"name\":\"Selank\"},{\"@type\":\"ListItem\",\"position\":47,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/semaglutide\/\",\"name\":\"Sema (Semaglutide)\"},{\"@type\":\"ListItem\",\"position\":48,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/semax\/\",\"name\":\"Semax\"},{\"@type\":\"ListItem\",\"position\":49,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/sermorelin\/\",\"name\":\"Sermorelin\"},{\"@type\":\"ListItem\",\"position\":50,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/sildenafil\/\",\"name\":\"Sildenafil\"},{\"@type\":\"ListItem\",\"position\":51,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/slu-pp-332\/\",\"name\":\"SLU-PP-332\"},{\"@type\":\"ListItem\",\"position\":52,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/snap-8\/\",\"name\":\"SNAP-8\"},{\"@type\":\"ListItem\",\"position\":53,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/sr9009\/\",\"name\":\"SR9009\"},{\"@type\":\"ListItem\",\"position\":54,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/survodutide\/\",\"name\":\"Survodutide\"},{\"@type\":\"ListItem\",\"position\":55,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/t3\/\",\"name\":\"T3\"},{\"@type\":\"ListItem\",\"position\":56,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/t4\/\",\"name\":\"T4\"},{\"@type\":\"ListItem\",\"position\":57,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/tadalafil\/\",\"name\":\"Tadalafil\"},{\"@type\":\"ListItem\",\"position\":58,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/tamoxifen-citrate\/\",\"name\":\"Tamoxifen citrate\"},{\"@type\":\"ListItem\",\"position\":59,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/tb-500\/\",\"name\":\"TB-500\"},{\"@type\":\"ListItem\",\"position\":60,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/tesamorelin\/\",\"name\":\"Tesamorelin\"},{\"@type\":\"ListItem\",\"position\":61,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/thymosin-alpha-1\/\",\"name\":\"Thymosin Alpha 1\"},{\"@type\":\"ListItem\",\"position\":62,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/tirzepatide\/\",\"name\":\"Tirz (Tirzepatide)\"},{\"@type\":\"ListItem\",\"position\":63,\"url\":\"https:\/\/lotilabs.com\/resources\/compounds\/yk-11\/\",\"name\":\"YK-11\"}]}]}<\/script><script>(function(){var i=document.querySelector('.cmp-lib-controls input');if(!i)return;i.addEventListener('input',function(){var q=i.value.trim().toLowerCase();document.querySelectorAll('.cmp-tile').forEach(function(t){t.style.display=!q||t.dataset.q.indexOf(q)>-1?'':'none'});document.querySelectorAll('[data-group]').forEach(function(g){g.style.display=[].some.call(g.querySelectorAll('.cmp-tile'),function(t){return t.style.display!=='none'})?'':'none'})})})();<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Specifications, current certificates of analysis and batch history for every compound in the Loti Labs research catalog.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3351","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/pages\/3351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=3351"}],"version-history":[{"count":1,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/pages\/3351\/revisions"}],"predecessor-version":[{"id":3352,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/pages\/3351\/revisions\/3352"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=3351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}